Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

When technology merges with humanity

Marc Arginteanu, MD
Conditions
September 10, 2024
Share
Tweet
Share

An excerpt from Nephilim.

“Those eggs really hit the spot, right?”

“I’d love some more,” he answered.

“Sure,” Zdenek responded. “One or two?”

“How many do we have?”

Before long, James had wolfed down nine eggs.

“I wonder if it’s the choline,” Zdenek mused as James shoveled. “Eggs have a boatload of choline. Maybe she’s craving it. Orange that is.” James hadn’t touched his toast. “Choline, you know? It might help my baby merge with your nerves.”

James’ face bore the same strange expression as when he’d gazed around his bedroom. “You remember that existentialism class I took last year?”

“Remember it?” Zdenek scoffed. “How could I forget? If it weren’t for me writing your final paper you would’ve walked away with a big fat ‘F’.”

“I think I understand what Sartre was saying now. Take this fork.” He licked Tabasco from the tines. “Like, it’s only the essence of a fork, to meet a purpose. This,” he regarded the fork as if he’d never seen one, “this thing popped into existence just so I could deliver this scrumptious pile of eggs into my mouth.”

James looked down at his legs in the same way, from one to the other. “And your machine—”

“Component. She’s just one component.”

“The machine is bonded to my leg. But a leg is just a leg. Yeah, just a leg. And I’ll still be James, regardless of how much the component changes my leg.” He stood up and walked across the room. “Hell, you could saw my leg right off and I’d still be James.”

Zdenek gulped hard and his left eye twitched. By now, the micro-tendrils of the component had infiltrated James’ nerves. They were inexorably advancing, inching millimeter by millimeter towards his brain, like leaves seeking sunlight. The component’s chief ambition (though not its sole desire) was to merge with James’ brain on a cellular level. The rest of it was just a side effect.

ADVERTISEMENT

“But what about when this thing of yours finds its way into my skull?” James said. He filled the sink with hot, sudsy water and scrubbed the dishes. “What then?”

“Um,” Zdenek said.

“Will I still be James?”

“Um.”

Marc Arginteanu is a neurosurgeon and author of Nephilim and Azazel’s Public House.

Prev

Legitimate vs. sham peer review (SPR): Is there a difference?

September 9, 2024 Kevin 0
…
Next

How a doctor with cerebral palsy defied the odds and transformed health care

September 10, 2024 Kevin 0
…

Tagged as: Neurology

Post navigation

< Previous Post
Legitimate vs. sham peer review (SPR): Is there a difference?
Next Post >
How a doctor with cerebral palsy defied the odds and transformed health care

ADVERTISEMENT

More by Marc Arginteanu, MD

  • Coconut oil’s role in Alzheimer’s and depression

    Marc Arginteanu, MD
  • How gut bacteria shape your mental health and mood

    Marc Arginteanu, MD
  • How the shingles vaccine could help prevent dementia

    Marc Arginteanu, MD

Related Posts

  • Honoring humanity: lessons from a medical encounter

    Ellie Qian
  • We are in the midst of a crisis in humanity

    Nicolo Geralde, DO
  • Use technology to fix medical education

    Jimmy J. Qian
  • People over profit: Pfizer and Moderna must share vaccine technology

    Amber Gipson-Fine, MPH
  • A message from a patient to health care workers: Always remember your humanity

    Michele Luckenbaugh
  • The evolution of medical training in dermatology and the impact of technology

    Peter Lio, MD

More in Conditions

  • Pancreatic cancer racial disparities

    Earl Stewart, Jr., MD
  • Why burnout prevention starts with leadership

    Kim Downey, PT & Shari Morin-Degel, LPC
  • Are SGLT2 inhibitors safe for type 1 diabetes?

    Zehra Haider, MD
  • Re-examining the lipid hypothesis and statin use

    Larry Kaskel, MD
  • How the internship shortage harms Black students

    Jonathan Lassiter, PhD
  • Aligning psychiatric care and hospital costs

    Lionel Pereira, MD
  • Most Popular

  • Past Week

    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • A sibling’s guide to surviving medical school

      Chuka Onuh and Ogechukwu Onuh, MD | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • What AI can never replace in medicine

      Jessica Wu, MD | Physician
    • Why the MAHA plan is the wrong cure

      Emily Doucette, MPH and Wayne Altman, MD | Policy
    • Why burnout prevention starts with leadership

      Kim Downey, PT & Shari Morin-Degel, LPC | Conditions
    • Are SGLT2 inhibitors safe for type 1 diabetes?

      Zehra Haider, MD | Conditions
    • ChatGPT in medicine: risks, benefits, and safer documentation strategies [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • A sibling’s guide to surviving medical school

      Chuka Onuh and Ogechukwu Onuh, MD | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • What AI can never replace in medicine

      Jessica Wu, MD | Physician
    • Why the MAHA plan is the wrong cure

      Emily Doucette, MPH and Wayne Altman, MD | Policy
    • Why burnout prevention starts with leadership

      Kim Downey, PT & Shari Morin-Degel, LPC | Conditions
    • Are SGLT2 inhibitors safe for type 1 diabetes?

      Zehra Haider, MD | Conditions
    • ChatGPT in medicine: risks, benefits, and safer documentation strategies [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...